TFBS Bioscience (ROCO:6939) EV-to-EBITDA : 19.00 (As of Dec. 13, 2024)

TFBS Bioscience EV-to-EBITDA Chart

Competitive Comparison of TFBS Bioscience's EV-to-EBITDA

For the Diagnostics & Research subindustry, TFBS Bioscience's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TFBS Bioscience's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where TFBS Bioscience's EV-to-EBITDA falls into.

TFBS Bioscience EV-to-EBITDA Calculation

TFBS Bioscience's EV-to-EBITDA for today is calculated as:

TFBS Bioscience's current Enterprise Value is NT$603.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TFBS Bioscience's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was NT$31.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience  (ROCO:6939) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

TFBS Bioscience's PE Ratio (TTM) for today is calculated as:

TFBS Bioscience's share price for today is NT$36.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TFBS Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.650.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

TFBS Bioscience EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of TFBS Bioscience's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

TFBS Bioscience Business Description